Novartis Sues Viatris, Others In New IP Fight Over Heart Drug
Amid Novartis' ongoing multidistrict patent litigation against generic-drug makers over the heart medication Entresto, the Swiss pharmaceutical giant has now targeted Viatris and others in a new Delaware federal court infringement...To view the full article, register now.
Already a subscriber? Click here to view full article